n-(Tert-butyl)-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 1g

2,2'-(Piperazine-1,4-diyl)diethanol, 95.0%, 500g

6-chloro-2-methyl-3,4-dihydropyrimidin-4-one, 95%, 5g

2-Chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]benzoic acid, 98%, 5mg

3-cyclopropyl-3-hydroxy-1-phenylprop-2-en-1-one, 98%, 5g

2-METHOXY-5-NITROPYRIMIDIN-4-AMINE, 95.0%, 5g

iScope IS.1153-EPL/DF Triocular with E-plan objectives and Rackless cross table (dark field contrast application)

2-Bromo-9,9-diphenyl-9H-fluorene, 95.0%, 25g

4-Amino-2-bromopyridine, 98.0%, 1g

Acenaphthylene, 95.0%, 100g

2,3-Dimethylbenzonitrile, 97.0%, 100g

1-Isopropenyl-4-trifluoromethyl-benzene, 25g

2,4-Dimethoxyaniline, 95.0%, 25g